Glucose Necessary For Cancer Growth May Prove To Be Its Weak Link
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered that cancer cells tap into a natural recycling system to obtain the energy they need to keep dividing. In a...
View ArticleFDA Approves Incyte’s Jakafi(TM) (Ruxolitinib) for Patients With Myelofibrosis
WILMINGTON, Del.– Incyte Corporation (Nasdaq: INCY) announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Jakafi™ (ruxolitinib) for the treatment of patients...
View ArticleFDA To Review Potential New Use Of XGEVA® (Denosumab) At Oncologic Drugs...
Amgen (NASDAQ: AMGN) announced the U.S. Food and Drug Administration (FDA) has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to...
View ArticleGSK announces positive vote from FDA panel for pazopanib in certain advanced...
GlaxoSmithKline announced today that the Oncologic Drugs Advisory Committee (ODAC) to the US FDA voted 11 to 2 that evidence from clinical studies support a favourable benefit – risk assessment for use...
View ArticleTwo Cancer-Promoting Pathways Linked In Esophageal Cancer
Identification of a non-traditional pathway for spiriting a cancer-promoting protein into the cell nucleus points to a possible combination therapy for esophageal cancer and indicates a mechanism of...
View Article
